On March 3, 2020, a soft-spoken physician named Dr. Matthew Hepburn took the stage on the TEDMED stage at the Westin Waterfront Hotel in Boston to...
High levels of mucosal IgA antibodies in the respiratory tract protect against SARS-CoV-2 infection for at least 8 months. Omicron infection produces durable mucosal antibodies, reducing...
In a recent study posted on bioRxiv* US researchers use a hamster model to study efficacy and immunity of an intranasal messenger ribonucleic acid (mRNA)-lipid nanoparticle...
In a recent study posted on Bio Rxiv*Preprint server, researchers evaluated the efficacy of a multivalent exosome-based coronavirus disease 2019 (COVID-19) vaccine. study: Exosome-Based Multivalent Vaccines:...
As Covid-19 enters its fourth year and countries around the world have largely given up on mass mitigation strategies such as masks and routine testing, vaccination...
A study of 160,000 people in 23 countries published in the journal found that acceptance of the COVID-19 vaccine increased by 5.2% overall in 2022 compared...
Recent Comments